CEO Brady Granier of BioCorRx, Inc.(OTCQB: BICX) returns to the show to discuss new board member additions, recent private placement, and plans to up list to the NASDAQ.

Alcoholism # Anahiem # implants # independent treatment providers # Naltrexone # out patient programs # pre IND meeting # recovery # support # therapy # opiode use disorder